Security key
31189P102
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)
CUSIP: 31189P102
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 122,342,805
- Total 13F shares
- 96,451,503
- Share change
- -4,432,746
- Total reported value
- $76,210,377
- Put/Call ratio
- 9.5%
- Price per share
- $0.79
- Number of holders
- 127
- Value change
- -$16,246,755
- Number of buys
- 56
- Number of sells
- 80
Report period
Q1 2025
Institutions
127
Top holders
10
FATE full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
FATE THERAPEUTICS INC SEC filings
FATE THERAPEUTICS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 31189P102
Recent filing periods:
Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
6.9%
from 13D/G
|
10,941,582
|
$18,053,611 | — | 31 Dec 2024 | |
| Redmile Group, LLC |
13F
|
Company |
11%
|
12,872,946
|
$21,240,361 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.4%
|
10,333,033
|
$17,049,505 | — | 31 Dec 2024 | |
| Bellevue Group AG |
13F
|
Company |
4%
|
4,839,779
|
$7,985,635 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.6%
|
4,382,257
|
$7,230,724 | — | 31 Dec 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.9%
|
3,555,871
|
$5,867,187 | — | 31 Dec 2024 | |
| JOHNSON & JOHNSON |
13F
|
Company |
2.8%
|
3,379,064
|
$5,575,456 | — | 31 Dec 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.7%
|
3,258,402
|
$5,376,363 | — | 31 Dec 2024 | |
| EcoR1 Capital, LLC |
13F
|
Company |
2.5%
|
3,049,405
|
$5,031,518 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.4%
|
2,898,377
|
$4,782,116 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2.3%
|
2,822,183
|
$4,656,600 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2%
|
2,476,414
|
$4,086,083 | — | 31 Dec 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
2%
|
2,465,000
|
$4,067,250 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.8%
|
2,227,295
|
$3,675,037 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
2,226,967
|
$3,675,218 | — | 31 Dec 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.5%
|
1,855,954
|
$3,062,324 | — | 31 Dec 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.4%
|
1,680,580
|
$2,772,957 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.4%
|
1,669,562
|
$2,754,778 | — | 31 Dec 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.3%
|
1,586,987
|
$2,618,529 | — | 31 Dec 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.3%
|
1,536,633
|
$2,535,444 | — | 31 Dec 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.2%
|
1,473,792
|
$2,430,000 | — | 31 Dec 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.2%
|
1,422,785
|
$2,347,595 | — | 31 Dec 2024 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
1.1%
|
1,379,556
|
$2,276,267 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.9%
|
1,103,393
|
$1,820,599 | — | 31 Dec 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.89%
|
1,083,092
|
$1,787,102 | — | 31 Dec 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.68%
|
828,100
|
$1,366,365 | — | 31 Dec 2024 | |
| Cerity Partners LLC |
13F
|
Company |
0.67%
|
823,134
|
$28,206 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.66%
|
805,518
|
$1,329,106 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.64%
|
781,889
|
$1,290,117 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.63%
|
770,280
|
$1,270,962 | — | 31 Dec 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.49%
|
600,000
|
$990,000 | — | 31 Dec 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.44%
|
543,021
|
$895,985 | — | 31 Dec 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.42%
|
512,641
|
$845,857 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.34%
|
416,731
|
$687,609 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.34%
|
413,192
|
$681,767 | — | 31 Dec 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.32%
|
397,177
|
$655,342 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.31%
|
378,619
|
$624,721 | — | 31 Dec 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.3%
|
372,507
|
$614,637 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
0.29%
|
356,964
|
$588,991 | — | 31 Dec 2024 | |
| Bruce & Co., Inc. |
13F
|
Company |
0.29%
|
350,000
|
$577,500 | — | 31 Dec 2024 | |
| E Fund Management Co., Ltd. |
13F
|
Company |
0.28%
|
339,994
|
$560,990 | — | 31 Dec 2024 | |
| Monaco Asset Management SAM |
13F
|
Company |
0.27%
|
327,671
|
$540,657 | — | 31 Dec 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.26%
|
321,401
|
$530,312 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.26%
|
317,271
|
$523,496 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.25%
|
304,129
|
$501,812 | — | 31 Dec 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.24%
|
297,106
|
$490,225 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.24%
|
293,006
|
$483,460 | — | 31 Dec 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.24%
|
287,711
|
$474,723 | — | 31 Dec 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.2%
|
249,800
|
$412,170 | — | 31 Dec 2024 | |
| BIT Capital GmbH |
13F
|
Company |
0.2%
|
247,564
|
$408,481 | — | 31 Dec 2024 |
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q1 2025
As of 31 Mar 2025,
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by
127 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
96,451,503 shares.
The largest 10 holders included
Redmile Group, LLC, BlackRock, Inc., VANGUARD GROUP INC, Schonfeld Strategic Advisors LLC, CITADEL ADVISORS LLC, JPMORGAN CHASE & CO, JOHNSON & JOHNSON, BAKER BROS. ADVISORS LP, DIMENSIONAL FUND ADVISORS LP, and Vestal Point Capital, LP.
This page lists
129
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
154
Q1 2025 holders
127
Holder diff
-27
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.